Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia

Sumaira Khan1 Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USAView further author information

Kady Phe2 Department of Pharmacy, Baylor St. Luke's Medical Center, Houston, TX, USAView further author information

Vincent H. Tam1 Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USACorrespondence[email protected]
View further author information

References

Skoglund E, Ledesma KR, Lasco TM, Tam VH. Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates. J Glob Antimicrob Resist. 2017;11:154–5.
PubMed Web of Science ®Google Scholar
Bassetti M, Castaldo N, Cattelan A, Mussini C, Righi E, Tascini C, et al. Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Int J Antimicrob Agents. 2019;53(4):408–15.
PubMed Web of Science ®Google Scholar
Tumbarello M, Repetto E, Trecarichi EM, Bernardini C, De Pascale G, Parisini A, et al. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect. 2011;139(11):1740–9.
PubMed Web of Science ®Google Scholar
Phe K, Heil EL, Tam VH. Optimizing pharmacokinetics-pharmacodynamics of antimicrobial management in patients with sepsis: a review. J Infect Dis. 2020;222(Supplement_2):S132–S41.
PubMedGoogle Scholar
Ruiz J, Ferrada A, Salavert M, Gordon M, Villarreal E, Castellanos-Ortega Á, et al. Ceftolozane/tazobactam dosing requirements against Pseudomonas aeruginosa bacteremia. Dose Response. 2020;18:1–6.
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real life experience with ceftolozane/tazobactam therapy for Pseudomonas aeruginosa bacteremia

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date